Revolution Medicines (RVMD) Competitors $38.74 -1.73 (-4.27%) Closing price 04:00 PM EasternExtended Trading$40.29 +1.55 (+4.00%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RVMD vs. BNTX, ONC, TEVA, SMMT, ITCI, GMAB, RDY, VTRS, MRNA, and QGENShould you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include BioNTech (BNTX), Beigene (ONC), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Moderna (MRNA), and Qiagen (QGEN). These companies are all part of the "pharmaceutical products" industry. Revolution Medicines vs. BioNTech Beigene Teva Pharmaceutical Industries Summit Therapeutics Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Viatris Moderna Qiagen BioNTech (NASDAQ:BNTX) and Revolution Medicines (NASDAQ:RVMD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, community ranking, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership. Is BNTX or RVMD more profitable? Revolution Medicines has a net margin of 0.00% compared to BioNTech's net margin of -15.16%. BioNTech's return on equity of -2.35% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets BioNTech-15.16% -2.35% -2.05% Revolution Medicines N/A -33.67%-30.08% Does the MarketBeat Community favor BNTX or RVMD? BioNTech received 45 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 78.03% of users gave Revolution Medicines an outperform vote while only 47.44% of users gave BioNTech an outperform vote. CompanyUnderperformOutperformBioNTechOutperform Votes14847.44% Underperform Votes16452.56% Revolution MedicinesOutperform Votes10378.03% Underperform Votes2921.97% Do institutionals & insiders have more ownership in BNTX or RVMD? 15.5% of BioNTech shares are held by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are held by institutional investors. 19.2% of BioNTech shares are held by insiders. Comparatively, 8.2% of Revolution Medicines shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts rate BNTX or RVMD? BioNTech currently has a consensus target price of $142.08, indicating a potential upside of 43.51%. Revolution Medicines has a consensus target price of $67.08, indicating a potential upside of 72.96%. Given Revolution Medicines' stronger consensus rating and higher probable upside, analysts plainly believe Revolution Medicines is more favorable than BioNTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNTech 0 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 2.89Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to BNTX or RVMD? In the previous week, Revolution Medicines had 5 more articles in the media than BioNTech. MarketBeat recorded 23 mentions for Revolution Medicines and 18 mentions for BioNTech. BioNTech's average media sentiment score of 1.19 beat Revolution Medicines' score of 1.06 indicating that BioNTech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioNTech 8 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 14 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, BNTX or RVMD? BioNTech has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Which has stronger earnings & valuation, BNTX or RVMD? BioNTech has higher revenue and earnings than Revolution Medicines. BioNTech is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNTech$2.75B8.67$1.01B-$3.40-29.12Revolution Medicines$742K9,736.39-$436.37M-$4.00-9.70 SummaryBioNTech beats Revolution Medicines on 11 of the 19 factors compared between the two stocks. Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVMD vs. The Competition Export to ExcelMetricRevolution MedicinesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.26B$2.94B$5.40B$8.53BDividend YieldN/A1.72%5.22%4.11%P/E Ratio-10.8531.1826.7419.97Price / Sales9,736.39407.34394.93122.22Price / CashN/A168.6838.2534.62Price / Book3.503.346.874.59Net Income-$436.37M-$72.17M$3.23B$248.18M7 Day Performance-1.76%6.07%5.01%2.15%1 Month Performance6.09%9.51%12.82%16.14%1 Year Performance-2.21%-27.14%17.63%8.06% Revolution Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVMDRevolution Medicines4.4108 of 5 stars$38.74-4.3%$67.08+73.2%+1.1%$7.22B$742,000.00-10.79250Positive NewsBNTXBioNTech2.803 of 5 stars$97.27+4.9%$142.73+46.7%+10.0%$23.34B$2.75B-46.323,080News CoverageONCBeigene2.721 of 5 stars$233.25+0.5%$319.00+36.8%N/A$23.07B$4.18B-28.319,000Gap DownTEVATeva Pharmaceutical Industries3.3111 of 5 stars$17.92+5.8%$24.43+36.4%-0.4%$20.31B$16.62B-12.3636,800Positive NewsOptions VolumeSMMTSummit Therapeutics3.1907 of 5 stars$25.26+5.4%$37.40+48.1%+437.2%$18.76B$700,000.00-90.21110Positive NewsITCIIntra-Cellular Therapies0.8721 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560GMABGenmab A/S3.4467 of 5 stars$19.93+2.9%$39.17+96.5%-31.5%$12.78B$21.64B11.451,660News CoverageHigh Trading VolumeRDYDr. Reddy's Laboratories2.3333 of 5 stars$13.93+3.9%$17.00+22.1%+5.3%$11.62B$311.31B22.1724,800Positive NewsGap UpVTRSViatris2.0946 of 5 stars$8.96+2.2%$10.50+17.2%-19.8%$10.63B$14.33B-12.1137,000Trending NewsGap UpMRNAModerna4.4677 of 5 stars$25.70+6.0%$53.95+109.9%-80.2%$9.94B$3.14B-2.773,900News CoverageGap UpQGENQiagen4.0353 of 5 stars$42.92+2.5%$48.42+12.8%-3.4%$9.54B$1.98B119.526,030Positive News Related Companies and Tools Related Companies BNTX Alternatives ONC Alternatives TEVA Alternatives SMMT Alternatives ITCI Alternatives GMAB Alternatives RDY Alternatives VTRS Alternatives MRNA Alternatives QGEN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RVMD) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVMD Stock Free RVMD Stock Alerts